Denise Orzech
National Institutes of Health
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Denise Orzech.
Toxicologic Pathology | 2007
Kazuhiko Mori; Pamela E. Blackshear; Edward K. Lobenhofer; Joel S. Parker; Denise Orzech; Joseph H. Roycroft; Kimwa L. Walker; Kennita Johnson; Tiwanda Marsh; Richard D. Irwin; Gary A. Boorman
Metabolism studies are crucial for data interpretation from rodent toxicity and carcinogenicity studies. Metabolism studies are usually conducted in 6 to 8 week old rodents. Long-term studies often continue beyond 100 weeks of age. The potential for age-related changes in transcript levels of genes encoding for enzymes associated with metabolism was evaluated in the liver of male F344/N rats at 32, 58, and 84 weeks of age. Differential expression was found between the young and old rats for genes whose products are involved in both phase I and phase II metabolic pathways. Thirteen cytochrome P450 genes from CYP families 1–3 showed alterations in expression in the older rats. A marked age-related decrease in expression was found for 4 members of the Cyp3a family that are critical for drug metabolism in the rat. Immunohistochemical results confirmed a significant decrease in Cyp3a2 and Cyp2c11 protein levels with age. This indicates that the metabolic capacity of male rats changes throughout a long-term study. Conducting multiple hepatic microarray analyses during the conduct of a long-term study can provide a global view of potential metabolic changes that might occur. Alterations that are considered crucial to the interpretation of long-term study results could then be confirmed by subsequent metabolic studies.
Toxicologic Pathology | 2007
Donald M. Sells; Amy E. Brix; Abraham Nyska; Micheal P. Jokinen; Denise Orzech; Nigel J. Walker
This paper reviews respiratory tract lesions observed in rodents administered various chemicals by noninhalation routes. Chemicals administered by inhalation caused lesions in the respiratory tract and were well described; however, when chemicals were administered by noninhalation routes the effort to evaluate tissues for lesions may have been less or not considered, especially in the upper respiratory tract, and some lesions may have gone undetected. Lesions described in this review mostly occurred in rodent chronic noninhalation studies conducted by the National Toxicology Program; however, some were noted in studies of shorter duration. The nasal cavity was vulnerable to damage when chemicals were administered by noninhalation routes. Changes included respiratory epithelial hyperplasia, degeneration and necrosis of olfactory epithelium, olfactory epithelial metaplasia, adenoma, adenocarcinoma, squamous cell carcinoma, and neuroblastoma. In the lung, compound-related lesions included alveolar histiocytosis, alveolar epithelial hyperplasia, bronchiolar metaplasia of the alveolar epithelium, squamous metaplasia, alveolar/bronchial adenoma and carcinoma, and squamous tumors. Pathogenesis of these lesions included regurgitation of volatiles, metabolites arriving from the blood stream, and additional metabolism by olfactory epithelium or Clara cells. The presence of respiratory tract lesions in noninhalation studies emphasizes the need for a thorough examination of the respiratory tract including nasal passages, regardless of the route of administration.
Toxicologic Pathology | 2004
June K. Dunnick; Warren Lieuallen; Carolyn F. Moyer; Denise Orzech; Abraham Nyska
We report that an environmental agent, bis(2-chloroethoxy)methane (CEM), caused cardiac toxicity in male and female F344 rats and B6C3F1 mice exposed to the chemical by dermal administration at doses of 0, 50, 100, 200, 400 or 600 mg/kg 5 days a week for up to 14 weeks. Treatment-related deaths occurred in 10/10 male and 10/10 female rats at 600 mg/kg, in 2/10 female rats at 400 mg/kg, and in 3/10 female mice at 600 mg/kg. The heart lesions were more severe in rats than mice, and more severe in females than males. In rats, the no-observed-adverse-effect level (NOAEL) for the heart lesions was 200 mg/kg for males and 100 mg/kg for females; in mice, it was more than 600 mg/kg for males and 200 mg/kg for females. Multifocal, widespread vacuolization of the myocytes comprised the main morphological feature of the lesions, and only in rats was it accompanied by mononuclear cell infiltration, myocytic necrosis and atrial thrombosis. Hearts from male rats were immunohistochemically stained for troponin T (cTnT) protein. Loss of cytoplasmic cTnT correlated with histopathological damage only in the 600 mg/kg animals. CEM is metabolized to thiodiglycolic acid, a chemical that causes mitochondrial dysfunction. It is hypothesized that mitochondrial damage leads to the heart toxicity from bis(2-chloroethoxy)methane.
Toxicologic Pathology | 2005
Abraham Nyska; Katsuhiko Yoshizawa; Micheal P. Jokinen; Amy E. Brix; Donald M. Sells; Michael E. Wyde; Denise Orzech; Grace E. Kissling; Nigel J. Walker
The National Toxicology Program recently completed a series of studies to evaluate the relative potency for toxicity and carcinogenicity of several polyhalogenated aromatic hydrocarbons including dioxin-like compounds (DLCs) and polychlorinated biphenyls. Female Sprague–Dawley rats were administered by gavage for up to 2 years with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD); 3,3′,4,4′,5-pentachlorobiphenyl (PCB126); 2,3,4,7,8-pentachlorodibenzofuran (PeCDF); 2,2′,4,4′,5,5′-hexachlorobiphenyl (PCB153); a tertiary mixture of TCDD, PCB126, and PeCDF; a binary mixture of PCB126 and 153; or a binary mixture of PCB126 and 2,3′,4,4′,5-pentachlorobiphenyl (PCB118); control animals received corn oil-acetone vehicle (99:1) alone. Nasal epithelial changes were observed only in animals exposed for 2 years to the higher doses of the binary mixtures of PCB126 + PCB153 (1000 ng/kg and 1000 ug/kg) and PCB126 + PCB118 (216 and 360 ng TCDD equivalents/kg). In both studies, the changes were of the same nonneoplastic nature, localized to nasal sections II and III located, respectively, at the level of the incisive papilla anterior to the first palatial ridge (section II) and through the middle of the second molar teeth (section III). The changes consisted of hyperplasia of the respiratory epithelium (level II) and metaplasia of olfactory epithelium to respiratory epithelium with further hyperplasia of the metaplastic respiratory epithelium (levels II and III). Variable amounts of acute inflammatory exudate appeared within the lumen of the nasal cavity, overlying the affected epithelium. Occasionally, the inflammation eroded through the skull and into the adjacent olfactory bulbs.
Toxicological Sciences | 2003
N. B. Ress; James R. Hailey; Robert R. Maronpot; John R. Bucher; Greg Travlos; Joseph K. Haseman; Denise Orzech; Jerry D. Johnson; Milton R. Hejtmancik
Toxicological Sciences | 2004
Katsuhiko Yoshizawa; Nigel J. Walker; Micheal P. Jokinen; Amy E. Brix; Donald M. Sells; Tiwanda Marsh; Michael E. Wyde; Denise Orzech; Joseph K. Haseman; Abraham Nyska
Environmental Health Perspectives | 2004
Abraham Nyska; Micheal P. Jokinen; Amy E. Brix; Donald M. Sells; Michael E. Wyde; Denise Orzech; Joseph K. Haseman; Gordon P. Flake; Nigel J. Walker
Food and Chemical Toxicology | 2004
Michelle J. Hooth; Robert C. Sills; L.T. Burka; Joseph K. Haseman; Kristine L. Witt; Denise Orzech; A.F. Fuciarelli; S.W. Graves; Jerry D. Johnson; John R. Bucher
Toxicology | 2004
Michelle J. Hooth; Ronald A. Herbert; Joseph K. Haseman; Denise Orzech; Jerry D. Johnson; John R. Bucher
Archive | 2005
Donald M. Sells; Abraham Nyska; Gordon P. Flake; Michael P. Jokinen; Nigel J. Walker; Michael E. Wyde; Joseph K. Haseman; Denise Orzech; Amy E. Brix